GRDX vs GRI

GridAI Technologies Corp. vs GRI Bio, Inc. — Valuation Comparison 2026

GRDX

Pharmaceutical Preparations
GridAI Technologies Corp.
Quality
4.4
out of 10
Value Trap
29
LOW
Price
$5.61
Last close
Models
9/13
Active
VS

GRI

Pharmaceutical Preparations
GRI Bio, Inc.
Quality
3.9
out of 10
Value Trap
15
SAFE
Price
$2.06
Last close
Models
6/13
Active

Model-by-Model Comparison

ModelType GRDX Fair ValueGRDX Upside GRI Fair ValueGRI Upside
Bayesian DCF Intrinsic $0.69 -87.8% $3.99 +93.7%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $0.17 -96.4% $0.05 -97.9%
Dynamic NAV Asset-Based $0.12 -97.8%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for GRDX vs GRI — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

GRDX vs GRI — Which Stock Is More Undervalued?

GRDX scores higher with a 4.4/10 quality rating vs GRI's 3.9/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing GridAI Technologies Corp. (GRDX) and GRI Bio, Inc. (GRI) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

GRDX currently trades at $5.61 with a QOC of 4.4/10, while GRI trades at $2.06 with a QOC of 3.9/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).